AAAAAA

   
Results: 1-3 |
Results: 3
Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial
Authors: Lam, W Gill, JB Trask, RV Mallavarapu, CT Rocha-Singh, KJ Mikell, FL Mishkel, GJ Mayer, SA Aguirre, FV Yakel, D Steen, MS Kacich, RL Shelton, ME Chaitman, BR Stocke, K Katholi, R Pianfetti, L Tatum, M McMillan, S Ligon, RW Holloway, C Cohen, DJ Staten, N Laswell, K Sullivan, P Rothert, T Page, L Brooks, M Entwistle, K Drew, D
Citation: W. Lam et al., Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial, AM HEART J, 141(3), 2001, pp. 402-409
Active Worlds (TM)
Authors: Tatum, M
Citation: M. Tatum, Active Worlds (TM), COMPUT GR, 34(2), 2000, pp. 56-57
Summary judgment and partial judgment in Louisiana: The state we're in
Authors: Tatum, M Norris, W
Citation: M. Tatum et W. Norris, Summary judgment and partial judgment in Louisiana: The state we're in, LA LAW REV, 59(1), 1998, pp. 131-173
Risultati: 1-3 |